• Persistence of Remission Among Patients With Inflammatory Bowel Disease After Adalimumab Therapy Is Stopped- Economic Implications

    Nov 1, 2015, 00:00
  • Multiple To Single Transition Probability- Hcv-Based Example

    Nov 1, 2015, 00:00
  • Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Quadrivalent Influenza Vaccine in Spain

    Nov 1, 2015, 00:00
  • Economic evaluations in infectious disease- which infections, what settings and what type of economic evaluations were reported in papers published in 2014?

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Adalimumab for The Treatment of Moderate-To-Severe Ulcerative Colitis In Patients In Spain

    Nov 1, 2015, 00:00
  • Políticas de Acesso ao Medicamento no Sistema Público de Saúde no Brasil

    Nov 1, 2015, 00:00
  • Identification of Subgroups With Low Rates of Weight Loss In Israel

    Nov 1, 2015, 00:00
  • Fda Breakthrough Status Versus Accelerated Approval – What’s the Difference?

    Nov 1, 2015, 00:00
  • Systematic Review of Economic Evaluations of Treatments In Epilepsy

    Nov 1, 2015, 00:00
  • Assessment of Content Equivalence and Usability Between the Paper and Electronic Versions of the Psoriasis Symptom and Sign Diary (Pssd) Among Subjects with Plaque Psoriasis

    Nov 1, 2015, 00:00
  • Consequences Of Biomarker Analysis On The Cost-Effectiveness Of Cetuximab In Combination With Irinotecan Based Chemotherapy For First-Line Treatment Of Metastatic Colorectal Cancer. Stratified Medicine At Work?

    Nov 1, 2015, 00:00
  • Clinical And Budget Impact Of Using A Molecular Test To Detect Kras Mutations In Metastatic Colorectal Cancer Patients In Denmark

    Nov 1, 2015, 00:00
  • Treatment Sequencing Patterns And Costs of Care in Patients with Relapsed/Refractory Multiple Myeloma

    Nov 1, 2015, 00:00
  • Costo Efectividad De La Adici”N De Bevacizumab Al Esquema De Primera Línea De Quimioterapia Carboplatino + Paclitaxel En Pacientes Con Cáncer De Pulm”N De Celula No Pequeña No Escamosa Con Ecog Entre 0 Y 1

    Nov 1, 2015, 00:00
  • Assessment of Dental Status and Perception Towards Oral Health Among Pharmacy Students In Quetta, Pakistan

    Nov 1, 2015, 00:00
  • Avaliação da Adesão Ao Protocolo de Tratamento de Pessoas Vivendo Com Hiv/Aids- Conhecer Bem Para Cuidar Melhor

    Nov 1, 2015, 00:00
  • One-Year Cost-Comparison Analysis Of Absorb™ Everolimus Eluting Bioresorbable Vascular Scaffold And Xience™ Everolimus Eluting Stent- Based On Findings From Absorb Ii

    Nov 1, 2015, 00:00
  • Validation of Fracture Risk Model In Japanese Women Compared With Frax

    Nov 1, 2015, 00:00
  • Identifying Practical Gaps to Comply with Cost-Effectiveness Guideline in Selecting Comparators in South Korea

    Nov 1, 2015, 00:00
  • Instructions for Authors

    Nov 1, 2015, 00:00
  • A National Eq-5d Value Set for Hungary - a Model Methodology ?

    Nov 1, 2015, 00:00
  • Assessment Of Renal Function Among Patients With Bone Metastases From Solid Tumors

    Nov 1, 2015, 00:00
  • The Relationship Between Knowledge and Performan The Case of Iran Community Pharmacies

    Nov 1, 2015, 00:00
  • Experienced Vs. Hypothetical Health States Preferences Using Eq-5d 3l And 5l Versions- A National Study

    Nov 1, 2015, 00:00
  • Epidemiological Data Presented in German Benefit Assessments – A Comparison between Pharmaceutical Companies and G-Ba

    Nov 1, 2015, 00:00
  • Sickness Funds Data Analyses on Prevalence Incidence And Treatment of Waldenstrom’s Macroglobulinemia (Wm) In Germany

    Nov 1, 2015, 00:00
  • Systematic Review Of Burden Of Cutaneous T-Cell Lymphoma

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Botulinum Toxin Type A Treatment for Cerebral Palsy In The Russian Federation

    Nov 1, 2015, 00:00
  • Ideglira Improves Health Utility Compared With Insulin Glargine In Patients With Type 2 Diabetes

    Nov 1, 2015, 00:00
  • Medication Error Identification Rate Among Medical Students of Quetta City, Pakistan

    Nov 1, 2015, 00:00
  • Estimation of Direct Medical Costs Associated with Treatment of Metastatic Melanoma in Switzerland

    Nov 1, 2015, 00:00
  • Long-Term Eq-5d Score For Patients With Metastatic Breast Cancer; Comparison Of First-Line Oral S-1 And Taxane Therapies In The Randomized “Select” Trial

    Nov 1, 2015, 00:00
  • Improved Visual Function Is Associated With Inflammation Reduction In Subjects With Non-Infectious Uveitis (Niu) of The Posterior Segment Treated With Intravitreal Sirolimus- ResultsFrom Sakura Study 1

    Nov 1, 2015, 00:00
  • Reimbursement of Telemedicine in Germany- Quo Vadis - Anything Beyond Selective Contracts?

    Nov 1, 2015, 00:00
  • The Under-Recognised Human and Economic Impact of Chronic Rhinosinusitis

    Nov 1, 2015, 00:00
  • Clinical and Economic Burden of Pulmonary Excerbations In Patients With Cystic Fibrosis Who are Homozygous For The F508del Mutation

    Nov 1, 2015, 00:00
  • Factors Associated with the Risk of Diabetes-Related Events- A Retrospective Analysis

    Nov 1, 2015, 00:00
  • Can Data Simulation Help Evaluate Hta Outcomes Over Time and Facilitate Early Decision-Making? a Case Study of Ticagrelor in Acute Coronary Syndrome in the Uk

    Nov 1, 2015, 00:00
  • Do European Patients Have A Shared Preference For The Benefits And Risks Of Medicines?

    Nov 1, 2015, 00:00
  • Modeling the cost-effectiveness of a new covered stent (willis) vs. Endovascular coil occlusion for the treatment of intracranial aneurysms in china

    Nov 1, 2015, 00:00
  • Efetividade E Segurança Da Glargina Vs Detemir E Nph No Tratamento De Pacientes Com Diabetes Tipo 1 – Revisão Sistemática E Metanálise

    Nov 1, 2015, 00:00
  • Model-Based Techniques In The Early Phases of The Medical Device Development- A Systematic Literature Review

    Nov 1, 2015, 00:00
  • Cancer Drug Funding Decisions in the UK- Innovation And Value in the Biologics Era

    Nov 1, 2015, 00:00
  • Minimun Indicators To Evaluate Management and Clinical Results in Institutions Assisting Patients Living with Hiv in Colombia

    Nov 1, 2015, 00:00
  • A Discrete Choice Experiment (Dce) To Elicit Preferences For Attributes Of A Bedside Pharmacogenetic Test – Preliminary Results

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

    Nov 1, 2015, 00:00
  • An Eq-5d-3l Value Set For Trinidad And Tobago

    Nov 1, 2015, 00:00
  • Heterogeneity in the Definition of Drug Induced Hypoglycemia in Clinical Trials- A Review

    Nov 1, 2015, 00:00
  • Are Trends in Spending on Oncology Treatments Sustainable?- Analysis of Sales Patterns in Major Global Markets

    Nov 1, 2015, 00:00
  • Medical Devices For Patients With Incontinence. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00
  • Mortality Due To Cardiovascular Disease In Colombia, 1998-2011

    Nov 1, 2015, 00:00
  • Analysis of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2014 In Spain

    Nov 1, 2015, 00:00
  • Research And Evaluation of the Self-Treatment Process with the Non-Steroidal Anti- Inflammatory Drugs in the Republic of Armenia

    Nov 1, 2015, 00:00
  • The impact of the u.s. Odac decision on avastin prescribing for metastatic breast cancer

    Nov 1, 2015, 00:00
  • Establishing the Value of Emerging Biosimilars

    Nov 1, 2015, 00:00
  • Acrysof Cachet Para la Corrección de Moderada a Alta Miopía- Una Revisión Sistemática y Meta-Análisis

    Nov 1, 2015, 00:00
  • Methodological Guidelines for Economic Drug Evaluation Studies in Portugal- Major Gaps and New Topics in the Studies Evaluated Between 2010 and 2014

    Nov 1, 2015, 00:00
  • Mapping of the 16-Item Sort form Version of the Menopause Cervantes Health-Related-Quality-of-Life Scale onto the Eq-5d-3l

    Nov 1, 2015, 00:00
  • Cost Analysis of the Diabetic Treatment in Italy- The Role of Vildagliptin vs. Other Therapeutic Options in Patients with Type 2 Diabetes with Renal Insufficiency

    Nov 1, 2015, 00:00
  • Economic Analysis of Paliperidone Long-Acting Acting Injectable for Chronic Schizophrenia in Portugal

    Nov 1, 2015, 00:00
  • Health-Related Quality of Life in Patients with Localized Prostate Cancer Using Eq- 5d- 3l

    Nov 1, 2015, 00:00
  • Costs of Relapse of Schizophrenia for the Argentinian Health System

    Nov 1, 2015, 00:00
  • Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00
  • Antidepressant use in Patients with Major Depressive Disorder- a Comparison of Treatment Resistant and Non-Treatment Resistant Episodes in the United Kingdom Using The Cprd Database

    Nov 1, 2015, 00:00
  • Extended-Release Oxycodone Hydrochloride (Oxycontin®) for Cancer Pain Management- a Cost Analysis from the Brazilian Public and Private Healthcare Systems Perspectives

    Nov 1, 2015, 00:00
  • Impact of Clerkship Attachments on Students’ Attitude Towards Pharmaceutical Care In Ethiopia

    Nov 1, 2015, 00:00
  • Role of Economics, Health, And Social And Political Stability In Determining Health Outcomes

    Nov 1, 2015, 00:00
  • Adoption Of Transcatheter Aortic Valve Replacement In Germany- Utilization Patterns And Case Volumes Compared To Surgical Aortic Valve Replacement In The Period 2009-2013

    Nov 1, 2015, 00:00
  • The Cost Of Acute Care Hospitalizations Associated With Chronic Heart Failure In Canada

    Nov 1, 2015, 00:00
  • Diareg - Diabetes Register Including Patient Reported Outcomes

    Nov 1, 2015, 00:00
  • What does Copd Exacerbation Means for Patients and for Healthcare?

    Nov 1, 2015, 00:00
  • Cost Per Qaly as a Potential Hurdle in Accessibility to Innovative Cancer Care in Selected Cee Countries

    Nov 1, 2015, 00:00
  • Sobrevida De Cinco Anos E Fatores Associados Ao Câncer De Boca Para Pacientes Em Tratamento Oncol”Gico Ambulatorial Pelo Sistema Único De Saúde, Brasil

    Nov 1, 2015, 00:00
  • Patients’ and Health Professionals’ Preferences Regarding Intravenous Vs Subcutaneous Drug Administration- A Literature Review

    Nov 1, 2015, 00:00
  • Cost-Utility of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Greece

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of the Information Technology Aided Relaps Prevention Programme in Schizophrenia (Itareps) in the Czech Republic

    Nov 1, 2015, 00:00
  • Tocilizumab in Methotrexate-Naïve Rheumatoid Arthritis – A Cost-Utility Model for Slovakia

    Nov 1, 2015, 00:00
  • Impact of Blood Transfusions on Hospital Length of Stay and Mortality- A Single-Center Experience

    Nov 1, 2015, 00:00
  • Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) in Public and Private System Versus Ppsv23 and No Vaccination in Older Adults

    Nov 1, 2015, 00:00
  • Dasatinib, High-Dose Imatinib And Nilotinib In Chinese Patients With Chronic Phase Of Chronic Myeloid Leukemia With Imatinib-Resistance Or -Intoleran An Economic Evaluation

    Nov 1, 2015, 00:00
  • Patient Count Forecasts of Advanced Non-Small Cell Lung Cancer- Results from the UK, Germany, France, Italy and Spain (Eu-5)

    Nov 1, 2015, 00:00
  • Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany

    Nov 1, 2015, 00:00
  • A Comparison of Market Access Evaluations for Type Ii Diabetes Mellitus In France and Germany- An Analysis Using The Prismaccess Database

    Nov 1, 2015, 00:00
  • Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2015, 00:00
  • Health Care Resource Utilization and Direct Medical Cost for Patients With Osteoporotic Fractures In Tianjin, China

    Nov 1, 2015, 00:00
  • Cost Analysis of Certolizumab Pegol Compared With Available Biologic Agents For Crohn’s Disease In Mexico And Brazil

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Early Parenteral Versus Enteral Nutrition In Critically Ill Patients

    Nov 1, 2015, 00:00
  • A Five-Year Model to Assess The Cost-Effectiveness of New Diagnostic Tests In The Early Diagnosis of Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Disinvestment Initiatives in Latin American Countries (Lac)- a Systematic Literature Review (Slr)

    Nov 1, 2015, 00:00
  • A Decision Tree Model To Evaluate The Costs And Consequences Of Using Dual Antibiotic Bone Cement Versus Single Antibiotic Bone Cement In Hip Hemiarthroplasty

    Nov 1, 2015, 00:00
  • Economic Evaluation and Added Value for Stakeholders of Switching From Rituximab Intravenous Injection to Rituximab Subcutaneous Injection In France

    Nov 1, 2015, 00:00
  • The Economic Impact of The use of Implantable Cardioverter Defibrillator In Primary Prevention

    Nov 1, 2015, 00:00
  • Challenges for Assessing The Economic Value of Orphan Drugs - A Literature Review of Current And Alternative Approaches

    Nov 1, 2015, 00:00
  • Self-Reported Medication Costs In Patients Receiving Sacral Neuromodulation For Overactive Bladder

    Nov 1, 2015, 00:00
  • Indiscriminate Prescription of Antibiotics and an Urgent Need of Legislation- A Survey from Pakistan

    Nov 1, 2015, 00:00
  • Knowledge, Attitude And Practices Towards Medication Use Among Post-Graduate Pharmacy Students

    Nov 1, 2015, 00:00
  • Análisis Del Comportamiento Del Cáncer De Mama En Una Aseguradora Colombiana

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Idelalisib In Combination With Rituximab For The Treatment Of Relapsed/Refractory Chronic Lymphocytic Leukemia (Cll) In Portugal

    Nov 1, 2015, 00:00
  • Pesquisa Nacional de Acesso a Medicamentos no Brasil - Percepção dos Usuários da Atenção Básica do Sistema Único de Saúde

    Nov 1, 2015, 00:00
  • Quality Of Life In Adult Intradural Primary Spinal Cord Tumors- Short Form–36 Correlates With The Scales Of Mccormick And Aminoff-Logue

    Nov 1, 2015, 00:00
  • Analisis de Costo Efectividad y Costo Utilidad del uso de Daclatasvir+Asunaprevir en el Tratamiento de Pacientes Con Hepatitis C en Colombia, Desde La Perspectiva Del Tercer Pagador

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Dasatinib as a Second-Line Therapy in Patients with Chronic Myelogenous Leukemia (Cml) in the Russian Federation

    Nov 1, 2015, 00:00
  • Systematic Review On Efficacy Of The F-18 Fluoromisonidazole Pet Or Pet/Ct

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Breast Cancer In Greece

    Nov 1, 2015, 00:00
  • Copd Performance Indicators In An Integrated Care Program And Its Impact On Health Outcomes- The Recode Cluster Randomized Trial

    Nov 1, 2015, 00:00
  • Revealed Opportunism- How Physicians Game Prior Authorization Protocols Until They Are Rescinded

    Nov 1, 2015, 00:00
  • Modelo De Caracterización De Una Población Afiliada A Una Asegurada En Colombia, Mediante Una Metodología De Agrupación Por Riesgo

    Nov 1, 2015, 00:00
  • Using Geographic Information Systems and Multi-Criteria Decision Analysis to Address Spatially Explicit Problems in Healthcare Policy Decision Making

    Nov 1, 2015, 00:00
  • Evaluacion Economica Del Manejo Farmacologico Del Paciente Con Hiperplasia Prostatica Benigna En Colombia

    Nov 1, 2015, 00:00
  • Financial Impact of Hospital Expenditure In Chronic Diseases For Seguro Popular

    Nov 1, 2015, 00:00
  • Expected Lifetime Numbers, Risks, And Burden of Fractures for 50-Year Old Chinese Women

    Nov 1, 2015, 00:00
  • Preliminary Outcomes of Health-Related Quality of Life in Hiv-Infected Naïve Patients

    Nov 1, 2015, 00:00
  • Burden Of Epilepsy In Colombia

    Nov 1, 2015, 00:00
  • Colorectal Cancer- the Importance of Being Right – a Model Investigating the Impact of Bowel Cleansing on Adenoma Detection in a German Screening Population

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Tocilizumab Subcutaneous As First Line Biologic Monotherapy for Rheumatoid Arthritis Management In Greece

    Nov 1, 2015, 00:00
  • Simpson’s Paradox- Why Smoking Reduces the Risk of Dying of Cardiovascular Disease

    Nov 1, 2015, 00:00
  • 4+ Years of Amnog – Clinical Drivers for Successful Dossier Submissions in Oncology

    Nov 1, 2015, 00:00
  • Impacto En La Supervivencia De La Gestion Y Atencion De Pacientes Con Cáncer De Prostata. Instituto De Cancerología Las Américas, Medellín (Colombia), 2013

    Nov 1, 2015, 00:00
  • Efficiency of A Personalized Care Model In Diabetes As An Example of Chronic Disease With Information and Communications Technology Support

    Nov 1, 2015, 00:00
  • The Burden of Cancer in Emerging Economies- Productivity Loss as an Alternative Perspective

    Nov 1, 2015, 00:00
  • Sun Exposure in Mexico- an Observational Study on Population Habits and Knowledge of Risks Associated with Such Exposure

    Nov 1, 2015, 00:00
  • A Management View On Health Economics - Case Study On Network Meta Analyses (Nma) For Pulmonary Arterial Hypertension (Pah)

    Nov 1, 2015, 00:00
  • Budget Impact Model of Omalizumab In The Treatment of Chronic Spontaneous Urticaria In Italy

    Nov 1, 2015, 00:00
  • Vedolizumab In Ulcerative Colitis; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00
  • Systematic Review Of Hyperkalemia Due To Angiotensin Enzyme Converting Inhibitors

    Nov 1, 2015, 00:00
  • Mortality Reduction From Gastric Cancer By Endoscopic Screening- 6-Years Follow-Up Of A Population-Based Cohort Study

    Nov 1, 2015, 00:00
  • Economic Impact of the Detection of Medication Errors in Oncological Patients with Afebrile Neutropenia in a Cancer Hospital

    Nov 1, 2015, 00:00
  • A Physician-Centered Intervention To Improve Control of Blood Pressure- Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00
  • A Dynamic Model To Estimate The Budget Impact Of A Neumococcal Vaccination Program In Spain

    Nov 1, 2015, 00:00
  • Age-Rationing - Reality or Virtue? A Study in Autoimmune Disease

    Nov 1, 2015, 00:00
  • Clinical And Economic Burden Of Asthma And Chronic Obstructive Pulmonary Disease (Copd) In Poland- Estimated Impact Of Poor Inhalation Technique With Inhaled Corticosteroid And Long-Acting Beta Agonist Fixed-Dose Combinations

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Ingenol Mebutate Versus Imiquimod 5% for Actinic Keratosis Treatment In Spain

    Nov 1, 2015, 00:00
  • Muscular Dystrophy Patients With Severe Renal Dysfunction- Analysis Of Ace-Inhibitor Use

    Nov 1, 2015, 00:00
  • Something Old, Something Borrowed, Something New- a Direct Comparison of Three Qualitative Elicitation Methods

    Nov 1, 2015, 00:00
  • Custo-Efetividade Do Tenofovir Para O Tratamento Da Hepatite B Crônica Uma Revisão Sistemática

    Nov 1, 2015, 00:00
  • Cost Effectiveness of Multidisciplinary Pain Management Services for Chronic Back Pain- Systematic Review

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Add-On To Metformin Plus Sulfonylurea In Patients With Type 2 Diabetes Mellitus (T2dm) In Brazil

    Nov 1, 2015, 00:00
  • Horizontal Vs. Vertical Equity- Market Access of Orphan Drugs In France and Uk

    Nov 1, 2015, 00:00
  • Análisis de Costo-Efectividad de Las Vacuna Antineumocóccicas Conjugadas en Colombia

    Nov 1, 2015, 00:00
  • A Systematic Review To Assess The Association Between The Use Of Antidepressants And Male-Only Cancers

    Nov 1, 2015, 00:00
  • Does Conditional Marketing Authorisation Influence Market Access in France, England, and Germany?

    Nov 1, 2015, 00:00
  • Estimating The Economic Burden Of Stroke In South India - A Cost-Of-Illness Study

    Nov 1, 2015, 00:00
  • Does Crgs Provide Proper Guides for An Efficient Pharmaceutical Prescription In Alzheimer Patients?

    Nov 1, 2015, 00:00
  • Economic Evaluation Of The Use Of Human Albumin In A Brazilian Public Hospital

    Nov 1, 2015, 00:00
  • Impact of Uncertainty In Predicted Risks on The Cost-Effectiveness of Risk-Stratified Preventive Treatment Strategies

    Nov 1, 2015, 00:00
  • Analysis of Evaluations Made by the uk Cancer Drug Fund Panel of Breast Cancer Treatments in Relation to Overall Scores and Final Cdf Decisions

    Nov 1, 2015, 00:00
  • Barriers to Intensification of Insulin Treatment In Patients With Type 2 Diabetes In The Netherlands- Assessing Patient Preferences And Behaviours

    Nov 1, 2015, 00:00
  • Isolation, Identification And Antimicrobial Susceptibility Testing of Salmonella From Selected Poultry Farms In Debre Zeit

    Nov 1, 2015, 00:00
  • Medical devices- have health technology assessment agencies started to focus more on them?

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Edoxaban Compared With Warfarin For The Prevention Of Stroke And Systemic Embolic Events In The Uk

    Nov 1, 2015, 00:00
  • Systematic Review of Fda Breakthrough Therapy Designated Products

    Nov 1, 2015, 00:00
  • Including Human Resource Constraints In Health Economic Evaluations

    Nov 1, 2015, 00:00
  • Budget Impact Analysis Of Tofacitinib For Rheumatoid Arthritis From The Perspective Of The Brazilian Private Healthcare System

    Nov 1, 2015, 00:00
  • Lipegfilgrastim For Reduction Of Chemotherapy-Induced Neutropenia Related Events- A Meta-Analysis

    Nov 1, 2015, 00:00
  • Variability in Clinical Comparators and Standards of Care- Consequences for Pan-European Relative Efficacy

    Nov 1, 2015, 00:00
  • Costo Efectividad de la Terapia Inmunomoduladora en Esclerosis Multiple Tipo Recaída Remision- Busqueda Sistemática de la Literatura

    Nov 1, 2015, 00:00
  • Pulmonary Arterial Hypertension (Pah)- Real-World Treatment Patterns, Outcomes And Costs Based On World Health Organization (Who) Functional Class (Fc)

    Nov 1, 2015, 00:00
  • From Centralized Marketing Authorization to National Reimbursement – A Challenging Journey for New Medical Products with Placebo Controlled Trials

    Nov 1, 2015, 00:00
  • Análisis Comparativo De Los Procesos De Decisión De Cobertura De Medicamentos Para Enfermedades Raras En Los Países De La Ocde

    Nov 1, 2015, 00:00
  • Costo De Cáncer De Prostata En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00
  • Copd Ics/Laba Treatment Inhalers and Their Impact on Adherence

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Local Insufflation Of Warm Humidified Co2 During Open And Laparoscopic Colorectal Surgery

    Nov 1, 2015, 00:00
  • Economic, Public Health, and Humanistic Impact of a Quadrivalent Human Papillomavirus (Hpv6/11/16/18) Vaccination Program for Females Age 9-11 Years in Mexico

    Nov 1, 2015, 00:00
  • Analysis of Government Procurements of Medicines for Rare Diseases In Russia

    Nov 1, 2015, 00:00
  • Dual Bronchodilation With Qva149 In Patients With Severe And Very Severe Copd – Are There Incremental Benefits For Portuguese Patients And For The Portuguese Nhs When Compared With Current Treatment Options In Portugal?

    Nov 1, 2015, 00:00
  • Comparative Effectiveness Analysis Of Mab In Asthma- The Importance Of Exacerbation Definition

    Nov 1, 2015, 00:00
  • Instrumentos Para la Incorporacion de la Evaluacion Economica, el Impacto Presupuestario y Los Esquemas de Pago por Resultados en el Servicio Catalán de Salud (España)

    Nov 1, 2015, 00:00
  • Long-Acting Insulin Analogues A Systematic Review of Systematic Reviews

    Nov 1, 2015, 00:00
  • Public Health and Economic Benefits of Quadrivalent Influenza Vaccine in Colombia

    Nov 1, 2015, 00:00
  • The Demographic Aspects of Turkish Chronic Hepatitis C Patients And The Treatment Initiation From A Physician’s Patient’s Point of View. First Interim Analysis of Turkish Data From Mosaic Study (An International Multicenter Prospective Obs ...

    Nov 1, 2015, 00:00
  • The Impact of Orthopaedic Surgery on The Quality of Life of Haemophilia Patients With or Without Inhibitors- A Systematic Review of The Literature

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis- Analysis Of Cost-Effectiveness Of Lanthanum-Carbonate (Lc) In Uncontrolled Hyperphosphatemia In Dialysis

    Nov 1, 2015, 00:00
  • A Comparison of Discrete Event Simulation (Des) Versus Markov Models With A Practical Application to Human-Immunodeficiency Virus (Hiv)

    Nov 1, 2015, 00:00
  • A Forma (in) Adequada do Aparato Vocal

    Nov 1, 2015, 00:00
  • Ethical Requirements for the Conduct of Drug Utilisation Studies Involving AD Hoc Data Collection- An International Cross-Sectional Survey

    Nov 1, 2015, 00:00
  • Direct And Indirect Costs Associated to Retinal Vascular Diseases In Italy. A Probabilistic Cost of Illness Study

    Nov 1, 2015, 00:00
  • Payer/Hta Requirements In Metastatic Breast Cancer

    Nov 1, 2015, 00:00
  • Acceptance of Clinically Relevant Primary Study Endpoints In The German Health Technology Assessment Process- Analysis of Five Different Disease Areas

    Nov 1, 2015, 00:00
  • Estimating the Lifetime Indirect Cost of Childhood Overweight and Obesity- A Markov Modelling Study

    Nov 1, 2015, 00:00
  • Best Practices for Network Meta-Analysis Methodology- Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00
  • The Effect Of Glucose Lowering Drug Use On Overall Mortality Among Breast Cancer Patients

    Nov 1, 2015, 00:00
  • Impacto Economico Del Tratamiento De Cancer De Cuello Uterino

    Nov 1, 2015, 00:00
  • Evolution Of The Number Of Patients Treated For Metastatic Cancer Between 2003 And 2013 In France

    Nov 1, 2015, 00:00
  • Re-Evaluating The Cost-Effectiveness of Screening For Congenital Adrenal Hyperplasia (Cah)- The Sensitivity to Choice of Distributions In Probabilistic Sensitivity Analyses (Psas)

    Nov 1, 2015, 00:00
  • Efficiency Of Expenses Of Gefitinibum In Patients With Non-Small Cell Lung Cancer As A Second Line Therapy

    Nov 1, 2015, 00:00
  • Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making- A Nominal Group Technique And Best-Worst Scaling

    Nov 1, 2015, 00:00
  • Patient Reported Outcomes (Pro) in Postprogression Oncology- Implications in Health Technology Assessments (Hta) Payer Decision Making

    Nov 1, 2015, 00:00
  • Cost Offsets Associated With Rebif Use In First-Line Rrms- An Analysis Based on The Cochrane Collaboration Review And Real-World Persistence Data

    Nov 1, 2015, 00:00
  • Attitudes of Medical Doctors And Pharmacists Toward Generic Substitution In Slovakia- First Results From Adopting The Law In 2012

    Nov 1, 2015, 00:00
  • Analysis of Nursing Activities And Health Care Need In Residential Social Care Institutions In Hungary

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of First-Line Disease-Modifying Therapies (Dmts) For Relapsing-Remitting Ms (Rrms)

    Nov 1, 2015, 00:00
  • Potential For Cost Savings Associated With A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- Italian Perspective

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of The Use of 18fdg-Pet/Ct In The Detection of Recurrent Differentiated Thyroid Cancer

    Nov 1, 2015, 00:00
  • A Comparison of Classification and Regression Trees and Logistic Regression for Predicting Death of Older Long-Term Care Users in Japan

    Nov 1, 2015, 00:00
  • Evaluating The Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus In Liver Transplant Patients Based on Data From Routine Clinical Practice

    Nov 1, 2015, 00:00
  • Psychometric Analysis And Validation of The Patient Satisfaction With Orthopaedic And Prosthetic Medical Devices, Modul Client Satisfaction With Device (Csd)

    Nov 1, 2015, 00:00
  • Effect of Pharmacist Interventions and Patient Reported Outcomes on Highly active Antiretroviral Therapy Counseling in Indian Hiv Postive Patients - A Prospective Study

    Nov 1, 2015, 00:00
  • Systematic Review Of Economic Evaluations In Personalized Medicine

    Nov 1, 2015, 00:00
  • Scoring and Responsiveness of the Self-Assessment of Treatment Version Ii Questionnaire in Patients with Painful Diabetic Peripheral Neuropathy

    Nov 1, 2015, 00:00
  • Burden Of Residual Skin and Joint Disease in Patients with Psoriatic Arthritis Treated with Biologics

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Apremilast In Moderate to Severe Psoriasis In Scotland

    Nov 1, 2015, 00:00
  • Espesor Corneal Central En Personas Sanas En Chile Y Correlación Entre Distintos Métodos De Medición

    Nov 1, 2015, 00:00
  • Economic Impact Of Drug-Related Morbidity In Sweden

    Nov 1, 2015, 00:00
  • A Method to Evaluate Uncertainty Due to Unknown Parameter Correlation in Stochastic Decision Models

    Nov 1, 2015, 00:00
  • Economic Evaluation of Lidocaine/Tetracaine Patch Versus Lidocaine/Prilocaine Cream for Topical Anaesthesia Before Vascular Access In Egypt

    Nov 1, 2015, 00:00
  • A Pct-Algorithm To Guide Antibiotic Therapy In Patients Hospitalized With Copd Exacerbations Leads To Net Cost Savings By Reducing Frequency And Duration Of Antibiotic Use As Compared To Current Practice

    Nov 1, 2015, 00:00
  • Methods to Account for Follow-Up Time Differences when Calculating Qalys from Randomised Controlled Trials

    Nov 1, 2015, 00:00
  • Impact on Time Gap Between Approval and Reimbursement of Target Therapy to Advanced Colorectal Cancer

    Nov 1, 2015, 00:00
  • Nice Decision Making- To Appeal or not to Appeal?

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Alternative Strategies Of Monitoring For Amiodarone-Related Thyroid Toxicity In Uk Primary Care

    Nov 1, 2015, 00:00
  • Happiness Effects on Health-State Valuations

    Nov 1, 2015, 00:00
  • Prevalence and Cost of Myasthenia Gravis In The Medicare Beneficiary Sample

    Nov 1, 2015, 00:00
  • Persistence To Vitamin-K Antagonists (Vka) And Novel Oral Anticoagulants (Noacs) In Non-Valvular Atrial Fibrillation (Nvaf)- An Observational Study Using A Comprehensive Regional Database In Catalonia, Spain

    Nov 1, 2015, 00:00
  • Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany

    Nov 1, 2015, 00:00
  • Identification of Factors Involved In Medication Complian Incorrect Inhaler Technique of Asthma Treatment Leads to Poor Compliance

    Nov 1, 2015, 00:00
  • The Role of Patient Level Data In Assessing Health Economic Value- A Case Study Using Edge and The Core Diabetes Model

    Nov 1, 2015, 00:00
  • Quality Of Life Of Patients Experiencing Cancer-Associated Thrombosis

    Nov 1, 2015, 00:00
  • Cambio de Copago de Medicamentos en España y Desigualdad

    Nov 1, 2015, 00:00
  • Drug Pricing Reform in China - Impact of the Reform from a Societal Perpsective

    Nov 1, 2015, 00:00
  • Effect of Transfer Factor on The Reduction of The Number of Episodes of Recurrent Infections In Adult And Pediatric Patients From A Multicentre Observational Study

    Nov 1, 2015, 00:00
  • Patient-Reported Outcomes In Studies Published In 2014- Which Tools Have Been Most Commonly Used In Studies Of Respiratory Disorders?

    Nov 1, 2015, 00:00
  • From Diagnosis To Treatment And Survival- The Emotional Journey Of Patients With Breast Cancer

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective

    Nov 1, 2015, 00:00
  • Complementary and Alternative Medicines (Cam) Among Diabetes Patients- A Prospective Study From Pakistan

    Nov 1, 2015, 00:00
  • Economic Burden of Patients with Alk+ Mutation non-Small Cell Lung Cancer After Treatment with Crizotinib- a Canadian Retrospective Observational Study

    Nov 1, 2015, 00:00
  • Prevalence and Perception of Use of Non-Prescription Medicines among Medical Student in Quetta, Pakistan

    Nov 1, 2015, 00:00
  • Measuring Health Care Performance on Equity- A Framework Using National Administrative Data from 2004/5 to 2011/12

    Nov 1, 2015, 00:00
  • How to Handle Levels of Evidence In Health Economic Modelling

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Recommended Medical Intervention for Treatment of Dysmenorrhea and Endometriosis in Japan Setting

    Nov 1, 2015, 00:00
  • Outcomes Used In Clinical Studies In Adult Hematoncology- Ten Years Of Publications In Pubmed

    Nov 1, 2015, 00:00
  • Analysis Of Differences In Hta Reimbursement Decisions Of Stage Iv (Metastatic) Breast Cancer Medications Across Different Countries

    Nov 1, 2015, 00:00
  • Differences In Disease Specific Hrqol In Rrms Patients Initiated on Oral Dmf Or Platform Therapies In Europe And Us

    Nov 1, 2015, 00:00
  • Use of A Multi-Decision Criteria Analysis to Support Healthcare Decision-Making for Private Payers in Brazil- Development of a Model To Guide Reimbursement Decisions

    Nov 1, 2015, 00:00
  • Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis- Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and S ...

    Nov 1, 2015, 00:00
  • A Cross-Sectional Study on Insulin Treatments and Glycemic Control in Type 2 Diabetes in France, Italy, Germany, UK and Spain

    Nov 1, 2015, 00:00
  • Cost-Utility of Bariatric Surgery In France And Germany

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of The Non-Vitamin K Antagonist Oral Anticoagulants For Atrial Fibrillation In Portugal

    Nov 1, 2015, 00:00
  • Engaging Hispanic Caregivers in Research- A Framework to Design Culturally Sensitive Approaches for Engagement in Patient-Centered Outcomes Research

    Nov 1, 2015, 00:00
  • A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus

    Nov 1, 2015, 00:00
  • Costo-Efectividad De Octreotide Lar Comparado Con Terapia De Soporte Usual Para El Tratamiento De Tumores Neuroendocrinos De Intestino Medio En Colombia

    Nov 1, 2015, 00:00
  • Avaliaçao das Demandas da Isotretinoína Para o Tratamento da Acne Grave no Sistema Único de Saúde (Sus), Brasil

    Nov 1, 2015, 00:00
  • The Long-Term Cost-Effectiveness of Twice-Daily Exenatide with Insulin Glargine Versus Once-Daily Liraglutide with Insuline Detemir in Adult Patients with Type 2 Diabetes in Russia

    Nov 1, 2015, 00:00
  • Costs Of Overactive Bladder Symptoms Treatment With Solifenacin

    Nov 1, 2015, 00:00
  • Patterns of Care For Metastatic Pancreatic Cancer- Real World Data From The Brazilian Private Health System (Phs)

    Nov 1, 2015, 00:00
  • Prescription Algorithms- Impact On Statins

    Nov 1, 2015, 00:00
  • Comparison of current and preferred status of hta implementation in central and eastern europen countries

    Nov 1, 2015, 00:00
  • Relationship Between Patient Characteristics and Outcomes In Patients With Multiple Myeloma

    Nov 1, 2015, 00:00
  • Public Health and Economic Benefits of Quadrivalent Influenza Vaccine in Panama

    Nov 1, 2015, 00:00
  • Humanistic Burden in Dementia- Which Tools Were Most Commonly Used in Studies Published in Pubmed in 2014?

    Nov 1, 2015, 00:00
  • Optimizacion De La Quimioterapia En El Cáncer Epidermoide De Pulmon Avanzado, Antimetabolitos O Taxanos?

    Nov 1, 2015, 00:00
  • Economic Impact of Employment Status on The Social Cost of Morbid Obese Patients Submitted to Bariatric Surgery

    Nov 1, 2015, 00:00
  • Evaluation of Fractures In The Elderly In Austria And Drug Risk Factor Analysis Based on Claims Data

    Nov 1, 2015, 00:00
  • The Vaccine Portfolio Management Model as an Efficiency Tool for Japan

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson`S Disease

    Nov 1, 2015, 00:00
  • Determinantes Socioeconómicos De La Obesidad En Escolares Y Adolescentes En Colombia- Un Análisis Regional

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness of Bendamustine-Rituximab (Ben-R) Versus R-Chop for the First Line Treatment of Patients with Indolent Non-Hodgkin’s Lymphoma (Inhl) in Colombia

    Nov 1, 2015, 00:00
  • Are you at risk of cancer? Consider Where you live in england for Access to the Most Expensive Oncology Treatments

    Nov 1, 2015, 00:00
  • The Impact of the increasing Penetration of on-Patent Medicines on the Greek Pharmaceutical Market

    Nov 1, 2015, 00:00
  • Biological Agents for Patients With Rheumatoid Arthritis Who Had Failed Treatment With Methotrexate In The Spanish Clinical Setting- A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • The Cost Effectiveness of Agomelatine in the Treatment of Major Depressive Disorder

    Nov 1, 2015, 00:00
  • Examination of Stress and Psychosomatic Symptoms In Terms of Nurses’ Quality of Life

    Nov 1, 2015, 00:00
  • Health System Research Opportunities for Assessment of The National Health Care System

    Nov 1, 2015, 00:00
  • Assessment of Complementary and Alternative Medicine Use In Hepatitis-C Patients In Quetta, Pakistan

    Nov 1, 2015, 00:00
  • Effectiveness of A Community-Based Falls Prevention Program For The Elderly

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Increasing the Influenza Vaccination Rate in Adults with Type 2 Diabetes in Turkey

    Nov 1, 2015, 00:00
  • The Impact of Baseline Hba1c and Hba1c Trajectories on Time to Therapy Escalation In Type 2 Diabetes Mellitus

    Nov 1, 2015, 00:00
  • Use of Complementary And Alternative Medicines (Cam) In Diabetics Patients In Quetta

    Nov 1, 2015, 00:00
  • Progressive Innovation in Oncology- Valuing Outcomes Beyond Survival

    Nov 1, 2015, 00:00
  • Female Breast Cancer- Burden Of Disease In Portugal

    Nov 1, 2015, 00:00
  • Effect of The Reorganization of The Intensive Care Units System In Hungary

    Nov 1, 2015, 00:00
  • Budget Impact of Golimumab iv for Rheumatoid Arthritis in the Chilean Private Sector

    Nov 1, 2015, 00:00
  • Method Comparison Of Censoring Cost Analyses

    Nov 1, 2015, 00:00
  • Epidemiology And Healthcare Services Utilization for Rare Diseases In Italy

    Nov 1, 2015, 00:00
  • Comparison Of Epidermal Growth Factor Receptor (Egfr) Tested And Not-Tested Metastatic Non-Small Cell Lung Cancer (Mnsclc) Patient Cohorts In Europe

    Nov 1, 2015, 00:00
  • Patients’ choice of providers as a signal of quality of care. Evidence of twelve public hospitals in the province of buenos aires, argentina

    Nov 1, 2015, 00:00
  • Treatment Outcomes Among Hiv/Aids Patients Treated During Haart Therapy At Infectious Disease Clinic

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Modelling for Neuropathic Pain Treatments- An Exploration to Identify Comparative Importance of Model Parameters

    Nov 1, 2015, 00:00
  • A Web-Based Survey to Investigate the Extent of Awareness and Understanding for Biosimilar among Japanese Physicians and Pharmacists

    Nov 1, 2015, 00:00
  • Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil

    Nov 1, 2015, 00:00
  • Twenty-Year Trends In Diagnosis and Treatment of Alzheimer’s Disease

    Nov 1, 2015, 00:00
  • Sick-Pay Expenditures In Hungary According To Major Disease Groups

    Nov 1, 2015, 00:00
  • Descriptive Evaluation of Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Ovarian Cancer

    Nov 1, 2015, 00:00
  • The Impact of Biologic Therapy Versus Conventional Treatment on The Costs of Ankylosing Spondylitis Chronic Complications Under The Perspective of Brazilian Private Health Care System

    Nov 1, 2015, 00:00
  • Following Norway, Which Market Will Be Next to See Extreme Biosimilar Discounting?

    Nov 1, 2015, 00:00
  • Association Between Feeding Types and Iron Status In India

    Nov 1, 2015, 00:00
  • Clinical Evaluation Of Kanakasava And Swasanandam Gulika In Bronchial Asthma

    Nov 1, 2015, 00:00
  • Cost-Effectiveness and Cost-Utility of Home-Based Hypnotherapy Using Compact Disc Versus Individual Hypnotherapy By A Therapist for Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain (Syndrome)

    Nov 1, 2015, 00:00
  • Gender Differences in Physical Activity of Hungarian Adults- An Observatory Survey

    Nov 1, 2015, 00:00
  • Patient, Caregiver and Treatment Factors Associated with Medication Satisfaction Among Treated Patients in the Caregiver Perspective on Pediatric Adhd (Cappa) Study in Europe

    Nov 1, 2015, 00:00
  • Efficacy of Surgical Vs. Non-Surgical Treatment of Carpal Tunnel Syndrome (Cts)- A Systematic Review

    Nov 1, 2015, 00:00
  • Effects Of Clinical Computing Systems During Consultations On Smoking Cessation - Evidence Landscape From Randomized And Quasi Randomized Trials

    Nov 1, 2015, 00:00
  • A New Methodology to Define the Scope of The French « Liste-En-Sus »

    Nov 1, 2015, 00:00
  • The Italian 648/96 List- Approvals, Rejections and Methods In Aifa’s Evaluation Process Between January 2013 and May 2015

    Nov 1, 2015, 00:00
  • Knowledge, Attitude and Perception of Polio (Poliomyelitis) among General Public in Pakistan

    Nov 1, 2015, 00:00
  • Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies- A Canadian Retrospective Claims Analysis

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Omalizumab In Chronic Spontaneous Urticaria In The Netherlands

    Nov 1, 2015, 00:00
  • Radio-223 in the Treatment of Metastatic Castration Resistant Prostate Cancer with Bone Metastases- Budget Impact Analysis of the National Health Service

    Nov 1, 2015, 00:00
  • Clinical Trial Trends in Latin America- communicable Versus Non-Communicable Disease

    Nov 1, 2015, 00:00
  • Costs of Illness of Multiple Sclerosis In Sweden – A Population-Based Register Study

    Nov 1, 2015, 00:00
  • Análise da Produção de Avaliação de Tecnologias Em Saúde do Centro Colaborador do Sistema Único de Saúde (Sus), Brasil - Uma Parceria Entre o Governo E A Academia

    Nov 1, 2015, 00:00
  • Bone Pain And Bone Targeting Agent (Bta) Treatment Pattern In Patients With Bone Metastases (Bms) From Prostate Cancer (Pc) In Real World Setting In Europe

    Nov 1, 2015, 00:00
  • Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation Among People With Type 2 Diabetes Mellitus In Japan

    Nov 1, 2015, 00:00
  • How much is spent in vaccines across western europe countries?

    Nov 1, 2015, 00:00
  • Investigating Levels of Bacterial Resistance and Antibiotic Consumption in the St. Petersburg State Medical University

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis of the use of Everolimus Compared to Axitinib in Second Line Therapy of Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2015, 00:00
  • Cambios En La Percepción De La Calidad De Vida Relacionada Con La Salud Por Diferencias En El Acceso Y El Régimen De Afiliación En Bogotá

    Nov 1, 2015, 00:00
  • Cost Effectiveness Of Cetuximab In First Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer In The Uk- A Summary Of Economic Analyses Submitted To The National Institute For Health And Care Excellence (Nice)

    Nov 1, 2015, 00:00
  • Market Access Trends In Rare Disease Approvals In Europe From 2005 To 2014

    Nov 1, 2015, 00:00
  • Drug Utilization Study On Indian Elderly Ambulatory Patients Using Who Prescribing Indicators

    Nov 1, 2015, 00:00
  • Disinvesting In Low-Value Care- Opportunities And Challenges

    Nov 1, 2015, 00:00
  • How Important Is The Time Factor? Saving Lives Using Fire And Rescue Services

    Nov 1, 2015, 00:00
  • Economic Evaluation of The One-Step Scheme Compared With Two-Steps for Screening And Diagnosis of Gestational Diabetes In Colombia

    Nov 1, 2015, 00:00
  • Health Professional Students’ Willingness To Pay For Human Papillomavirus Vaccination And Factors Influencing Their Decision In Malaysia

    Nov 1, 2015, 00:00
  • Identificação Sistemática de Lacunas de Pesquisa no Âmbito da Saúde Mental Pelo Ministério da Saúde do Brasil

    Nov 1, 2015, 00:00
  • Key Drivers of Cost Effectiveness In Crohn’s Disease

    Nov 1, 2015, 00:00
  • Capturing Quality of Life (Qol) Data in Rare Indications- Case Study in Radioiodine-Refractory Thyroid Cancer (Rr-Dtc)

    Nov 1, 2015, 00:00
  • Multivariate Network Meta-Analysis- An Example In Type 2 Diabetes For The Analysis Of Glycaemic Control

    Nov 1, 2015, 00:00
  • A Novel Tool to Measure The Subjective Burden of Acute Post-Prandial Hyperglycaemia (Pphg)

    Nov 1, 2015, 00:00
  • Estudio de La Implementacion de la Exigencia de Bioequivalencia Sobre el Consumo de Medicamentos Durante Agosto 2009 a Noviembre 2014 en Chile

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis Patients In Spain

    Nov 1, 2015, 00:00
  • Development of a Discrete Choice Experiment to Assess Patients’ and Professionals’ Preferences for Home Enteral Nutrition

    Nov 1, 2015, 00:00
  • Assessing the Gap Between Evidence Based Indications for Radiotherapy and Actual Practice in European Countries

    Nov 1, 2015, 00:00
  • Association Between Knowledge and Medication Adherence In Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2015, 00:00
  • The Burden of Cancer in Jamaica

    Nov 1, 2015, 00:00
  • Systematic Review And Meta-Analysis Of The Effectiveness And Safety Of Combination Therapy With Glycopirronium-Indacaterol Compared With Other First Line Therapies In Patients With Chronic Obstructive Pulmonary Disease

    Nov 1, 2015, 00:00
  • A Systematic Review of the Humanistic Burden of Gout

    Nov 1, 2015, 00:00
  • Patient Preferences Concerning Alternative Net Treatment Options – The Piano-Study

    Nov 1, 2015, 00:00
  • Epidemiology And Treatment Of Soft Tissue Sarcoma In The Eu5

    Nov 1, 2015, 00:00
  • Assessment Of Patient-Reported Health Status In Chronic Thromboembolic Pulmonary Arterial Hypertension Patients Treated With Riociguat- 2-Year Results From The Chest-2 Extension Study

    Nov 1, 2015, 00:00
  • The Economic Burden of Primary Brain Tumors in Canada

    Nov 1, 2015, 00:00
  • Health Proffessionals Involvement In Politics A Means to Improving Healthcare Delivery and Healthcare Legislations for Healthcare Seekers In Africa

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Abatacept Compared to Adalimumab In Italy Based on A Head-To-Head Outcomes Study In Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Modeling The Cost-Effectiveness of Ilaprazole Vs. Omeprazole for The Treatment of Newly Diagnosed Duodenal Ulcer Patients In China

    Nov 1, 2015, 00:00
  • Does Budget Impact Affect Reimbursement Decisions Made by the Cancer Drugs Fund in England?

    Nov 1, 2015, 00:00
  • Effect Of Fingolimod On Disease Progressions, Relapse Rate And Brain Atrophy In Multiple Sclerosis Patients- Review Of Literature And Pharmacoeconomic Considerations

    Nov 1, 2015, 00:00
  • Quality Assessment of Diagnostic Studies- Study Designs Leading to High and Low Risk of Bias

    Nov 1, 2015, 00:00
  • Costs And Cost-Effectiveness Of Non-Invasive Prenatal Diagnosis (Nipt) For Detection Of Trisomy 21 In Sweden

    Nov 1, 2015, 00:00
  • Years of Working Life Lost Caused By Osteoarthritis In Portugal

    Nov 1, 2015, 00:00
  • The Analysis of Inpatients Cost of Breast Cancer in China, 2011

    Nov 1, 2015, 00:00
  • Willingness to Pay for One Quality Adjusted Life Years In Patients With Diabetes

    Nov 1, 2015, 00:00
  • Utility And Metrics Of Natural Language Processing On Identifying Patients For Pharmacoepidemiologic Studies

    Nov 1, 2015, 00:00
  • Thermodilution Technique For Vascular Access Flow Measurement- A Systematic Review

    Nov 1, 2015, 00:00
  • A Network Metanalysis Comparing The Efficacy of Biologics for The Treatment of Early Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Bariatric Surgery for The Treatment of Obesity In Australia

    Nov 1, 2015, 00:00
  • Comparison Of Overall Costs Between Alprostadil And Limb Amputation In Patients Affected By Peripheral Arterial Disease Stages Iii And Iv In Mexico

    Nov 1, 2015, 00:00
  • Economic Burden In Studies Published In 2014- What Type of Gastrointestinal Disorders, Interventions and Outcomes Have Been Most Commonly Assessed?

    Nov 1, 2015, 00:00
  • Asociación Significativa Entre La Enfermedad Voluminosa Cercana A Craneo Y Neuroeje Y La Infiltración Secundaria A Sistema Nervioso Central En Pacientes Con Linfoma Difuso De Células Grandes B

    Nov 1, 2015, 00:00
  • Epidemiology and Burden of Multiple Myeloma in Japan- a Systematic Review

    Nov 1, 2015, 00:00
  • Measuring the Impact of Multiple Sclerosis- Enhancing the Performance of the Msis-29 and Msws-12

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Rituximab in Treatmenting Diffuse Large B-Cell Lymphoma in China

    Nov 1, 2015, 00:00
  • Cost of Medication Nonadherence in Patients with Diabetes Mellitus

    Nov 1, 2015, 00:00
  • Adherence and Persistence to Allopurinol among Hypertensive Patients with Gout

    Nov 1, 2015, 00:00
  • Direct Cost and Medication Usage in Elderly Type 2 Diabetic Patients under Hospitalization among Insured Urban Population in China

    Nov 1, 2015, 00:00
  • Will Rating Scale Types And Disease Conditions Influence Concordance Between Cognitive Function Reported By Children And Their Parents?

    Nov 1, 2015, 00:00
  • The Italian Regional Access of New Cancer Drugs- An Example in Four Regions

    Nov 1, 2015, 00:00
  • Time Ratios Or Hazard Ratios- Accelerating Toward A New Approach?

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Cerebrolysin In The Treatment of Patients With Acute Ischemic Stroke Moderate and Severe Degrees of Severity In The Russian Federation

    Nov 1, 2015, 00:00
  • Assessing Copd Patients Burden Of Disease In A Fold-In-Fold-Out Discrete Choice Experiment

    Nov 1, 2015, 00:00
  • Content Validity of the Current Health Satisfaction Questionnaire (Ches-Q) Among People Living with Type 2 Diabetes Mellitus (T2dm) and Comorbid Chronic Kidney Disease (Ckd)

    Nov 1, 2015, 00:00
  • Efficacy And Safety of Antidiabetic Drugs Available on Brazilian Public Health System (Sus) – Regular Insulin, Nph Insulin, Metformin, Glibenclamide And Gliclazide – In Treatment of Type 2 Diabetes (T2dm) - Systematic Review And Meta-Analys ...

    Nov 1, 2015, 00:00
  • Systematic Review on Use of Economic Evidence in Clinical Guidelines

    Nov 1, 2015, 00:00
  • Evaluación De Costo De Efectividad Y Costo Utilidad Del Uso De Rivaroxabán En Pacientes Sometidos Quirúrgicamente Por Reemplazo De Cadera Y Rodilla, Frente A Enoxaparina En El Contexto Ecuatoriano

    Nov 1, 2015, 00:00
  • Earlier Detection And Treatment of Non-Alcoholic Fatty Liver Disease- An Economic Evaluation to Appraise An Innovative Diagnostic Pathway to Detect And Intervene Where There Are Known Risk Factors

    Nov 1, 2015, 00:00
  • Economic Evaluation Of Pegfilgrastim As Prophylaxis For Febrile Neutropenia In Patients With Solid Tumors Or Lymphoma Receiving Chemotherapy In Mexico

    Nov 1, 2015, 00:00
  • Patient-Reported Outcomes in Studies Published in 2014- which Tools have been most Commonly Used in Studies of Musculoskeletal Disorders?

    Nov 1, 2015, 00:00
  • Reducing Consumption Versus Maintaining Abstinen Market Access Challenges Facing a Novel Treatment Pathway for Alcohol Addiction in the Eu5

    Nov 1, 2015, 00:00
  • Herpes Zoster and Post-Herpetic Neuralgia Vaccination- Cost-Effectiveness Analysis In Portugal

    Nov 1, 2015, 00:00
  • Quantifying Costs of Medical Personnel Involved with Radiation therapy Using Administrative Databases

    Nov 1, 2015, 00:00
  • Treatment Patterns, Resource Utilization And Costs In Muscular Dystrophy Patients- Analysis Using Administrative Claims Data

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Capnography Monitoring During Gastrointestinal Endoscopy Targeting Moderate Sedation

    Nov 1, 2015, 00:00
  • Real-World Patient Characteristics, Treatment Patterns, and Survival among Locally-Advanced/Metastatic Alk+ Non-Small Cell Lung Cancer Patients in Latin America

    Nov 1, 2015, 00:00
  • From Law To Reality- Measuring Time-To-Access Of Conitec Approved Drugs In Brazilian Public Health Care System (Sus) In The State Of Paraná

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Nexplanon® (Etonogestrel Implant) Compared to other Reimbursed Contraceptive Methods in France Based on Real Life Data

    Nov 1, 2015, 00:00
  • Changes Of Sick-Pay Expenditures In Hungary Between 2005-2013

    Nov 1, 2015, 00:00
  • Compound Attributes For Side Effect In Discrete Choice Experiments- Risk or Severity - What Is More Important to Hepatitis C Patients?

    Nov 1, 2015, 00:00
  • Panitumumab + Mfolfox6 Versus Bevacizumab + Mfolfox6 As First-Line Treatment of Wild-Type Ras Metastatic Colorectal Cancer- A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective

    Nov 1, 2015, 00:00
  • The Public Health Impact and Cost-Effectiveness of Pneumococcal Conjugate Vaccination In Estonia

    Nov 1, 2015, 00:00
  • Assessing The Efficiency Of The Long-Term Care Hospital Units In Hungary Between 2006 And 2013

    Nov 1, 2015, 00:00
  • The Association of Early Exposure to Phenols and Neuro-Behavior Developemnt In School-Aged Children

    Nov 1, 2015, 00:00
  • Pricing Policy for Pharmaceuticals in Egypt- Challenges and Opportunities

    Nov 1, 2015, 00:00
  • Use of Health Services In Brazil- A Systematic Review And Meta-Analysis of Prevalence Studies

    Nov 1, 2015, 00:00
  • Costo De Hipertension Arterial En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00
  • Strengths And Weaknesses of Current Clinical And Economic Evidence for The Comparison of Laparoscopic Versus Open Repair of Incisional Hernia

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada

    Nov 1, 2015, 00:00
  • Eunethta Members- What are their Roles within the National Setting?

    Nov 1, 2015, 00:00
  • Financial Impact of Not Prescribing “By The Book”- Art and Sustainability of Seguro Popular

    Nov 1, 2015, 00:00
  • Evaluation of Quality Assessment Tools for Non-Randomised Controlled Trials Assessing Surgical Interventions- A Systematic Review of Systematic Reviews

    Nov 1, 2015, 00:00
  • Economic Burden Of Adpkd From The Spanish Health System And Patient’s Perspective- Advantages Of Delaying Dialysis

    Nov 1, 2015, 00:00
  • A Systematic Literature Review To Identify And Compare Clinical Trials Evaluating Novel Therapeutic Agents In Post-Gemcitabine Advanced Pancreatic Cancer

    Nov 1, 2015, 00:00
  • Characterisitcs and Drug Utilization among Treated Chronic Hepatitis C Virus (Chc) Patients with and without Chronic Kidney Disease (Ckd) in the Us

    Nov 1, 2015, 00:00
  • Consistency In Search Strategies For Systematic Literature Reviews In Nice Submissions

    Nov 1, 2015, 00:00
  • Comparative Effectiveness Of Granulocyte Colony-Stimulating Factors (G-Csf) For Reducing Incidence Of Febrile Neutropenia (Fn) –Related Hospitalization- A Retrospective Cohort Study Using German Claims Data

    Nov 1, 2015, 00:00
  • Validating Approaches to Modelling End-Stage Renal Disease Using The Ims Core Diabetes Model

    Nov 1, 2015, 00:00
  • Impact of Decision Making Based on The Matching The Quality of The Early Warning Indicators In Colombia During 2013 – 2014 Between Private And Public Ips and The Quantity of Affiliates By Regimen

    Nov 1, 2015, 00:00
  • How Insurance Claim Data Can Help in Health Outcomes Research- an Indian Perspective

    Nov 1, 2015, 00:00
  • Hta Studies for Medical Devices Incorporating Their Moral Ageing

    Nov 1, 2015, 00:00
  • Daclatasvir +Asunaprevir Versus Sofosbuvir/Ledipasvir for The Treatment of Chronic Hepatitis C Genotype 1 In Japanese Patients- A Matching-Adjusted Indirect Comparison

    Nov 1, 2015, 00:00
  • Breast Cancer Patients’ Perception On Health Impacts From Receiving Chemotherapy

    Nov 1, 2015, 00:00
  • Patent Expiry and Generic Pricing- The Impact on Cost- Effectiveness Results

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93 (current)
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »